() RCT II 42 Aim: to evaluate the effects of calcium plus Supplementation had no significant effect on High risk of Vitamin D administration on metabolic status birth weight (p=0.88). bias; see and pregnancy outcomes in healthy pregnant Section 2.7 women Setting: Kashan, Iran Population: Pregnant women aged 18-40 years at week 25 of gestation Intervention: 500 mg calcium-200 IU cholecalciferol supplements (n=21) versus placebo (n=21) for 9 weeks. Subjects also consumed 400 folic acid daily μg from the beginning of the pregnancy and 50 mg ferrous sulfate from the second trimester. Outcomes: Secondary outcomes included birth size, gestational age, and mode of delivery.
() RCT II 42 Aim: to evaluate the effects of calcium plus Vitamin D administration on metabolic status and pregnancy outcomes in healthy pregnant women Setting: Kashan, Iran Population: Pregnant women aged 18-40 years at week 25 of gestation Intervention: 500 mg calcium-200 IU cholecalciferol supplements (n=21) versus placebo (n=21) for 9 weeks. Subjects also consumed 400 μg folic acid daily from the beginning of the pregnancy and 50 mg ferrous sulfate from the second trimester. Outcomes: Secondary outcomes included birth size, gestational age, and mode of delivery. Supplementation had no significant effect on birth weight (p=0.88). High risk of bias; see Section 2.7
Vitamin%20D%20evidence%20evaluation%2022May17.docx